Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
PCVX · against 173 other Healthcare companies of similar size
Ranked #52 of 174 · scores higher than 71% of peers · safety percentile 67
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)12 peers with a safety percentile of 60–69, including PCVX · Click a bar to see the companies
A mix: stronger current ratio and debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | PCVX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 169 reported | 0.04× | 0.34× | 80% | 33% | |
| BetaLower is better · 175 reported | 1.22 | 0.55 | 16% | 33% | |
| Current ratioHigher is better · 165 reported | 5.72× | 2.48× | 80% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 4.6B USD | 98 | 29 | |
| 48 | 921.9B INR (≈$11.1B) | 68 | 82 | |
| 49 | 138.4B HKD (≈$17.7B) | 68 | 70 | |
| 50 | 35.1B CNY (≈$4.9B) | 68 | 56 | |
| 51 | 10.7B USD | 67 | 78 | |
| 52 | 9.0B USD | 67 | 33 | |
| 53 | 871.6B INR (≈$10.5B) | 66 | 66 | |
| 54 | 9.3B AUD (≈$6.1B) | 66 | 55 | |
| 55 | 1.03T JPY (≈$7.0B) | 66 | 68 | |
| 56 | 80.2B CNY (≈$11.2B) | 66 | 76 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score